research-articleIndian Journal of Pharmaceutical Education and ResearchVol. 58 | Issue 2s | 2024 | pp. s429–s435Open access
An Exploration of Chrysin Fabricated Silver Nanoparticles as Antibiofilm Agent against Pseudomonas aeruginosa
- ,
- *
- 1 Department of Pharmaceutical Science, SHALOM Institute of Health and Allied Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Naini, Prayagraj, Uttar Pradesh, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Pushpraj S Gupta
Email: pushpraj.gupta@shiats.edu.in
Copyright: © 2024 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2024
- Received:
- May 26, 2023
- Accepted:
- Jan 19, 2024
- DOI:
- 10.5530/ijper.58.2s.46
How to cite
Lal, A. F., & Gupta, P. S. (2024). An Exploration of Chrysin Fabricated Silver Nanoparticles as Antibiofilm Agent against Pseudomonas aeruginosa. Indian Journal of Pharmaceutical Education and Research, 58(2s), s429–s435. https://doi.org/10.5530/ijper.58.2s.46
Abstract
Background
Pseudomonas aeruginosa (P. aeruginosa) is the source of serious nosocomial infections, the most common of which is ventilator-associated pneumonia. P. aeruginosa infections continue to pose a substantial therapeutic problem. The expression of several virulence genes and the formation of biofilms in bacteria are caused by quorum sensing, a density-dependent cell-to-cell communication mechanism. Anti-biofilm chemicals prevent the synthesis of the polymer matrix, limit cell adhesion and attachment, reduce the generation of virulence factors, and obstruct the quorum sensing system. The present study focused on the antibiofilm activity of chrysin-fabricated silver nanoparticles (nano-chrysin) against P. aeruginosa.
Materials and Methods
In our study, chrysin, which is a polyphenol, was fabricated with silver nanoparticles to make nano-chrysin. P. aeruginosa PAO1 strain was treated at sub-MIC concentrations with chrysin (50, 25, 12.5, and 6.25 μg mL-1), silver nanoparticles (6.26, 3.13, 1.56, and 0.78 μg mL-1) and formulated nano-chrysin (3.13, 1.56, 0.78, and 0.39μg mL-1) to find out the effectiveness of these compounds against biofilm formation.
Results
Biofilm produced by P. aeruginosa PAO1 was found to be inhibited at sub-MIC concentrations (3.13, 1.56, 0.78, and 0.39 μg mL-1) of nano-chrysin having MIC value ranging between 50-3.13 μg mL-1 which is more potent than alone chrysin and silver nanoparticles.
Conclusion
The data confirmed that nano-chrysin is effective in inhibiting biofilm formation, produced by P. aeruginosa.
Keywords
Subject
Article metadata
| Title | An Exploration of Chrysin Fabricated Silver Nanoparticles as Antibiofilm Agent against Pseudomonas aeruginosa |
|---|---|
| Authors | Arnica F Lal; Pushpraj S Gupta |
| Affiliations | Department of Pharmaceutical Science, SHALOM Institute of Health and Allied Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Naini, Prayagraj, Uttar Pradesh, INDIA. |
| Corresponding author | pushpraj.gupta@shiats.edu.in |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 58, Issue 2s (2024) |
Also in this issue
- Clinical Efficacy and Safety of Ceftriaxone in Surgical Prophylaxis: A Systematic Review and Meta-Analysispp. s332–s339
- Effectiveness of Complementary and Alternative Medicine and Physical Therapies in Peripheral Arterial Disease with Intermittent Claudication: A Systematic Reviewpp. s340–s353
- Implementation of National Education Policy 2020 in Pharmacy Educationpp. s354–s358
- A Biochemical and Molecular Insight to Wound Healing Properties of Traditional Indian Medicines in Normal and Diabetic Ratspp. s359–s371
- Chlorogenic Acid, a Potential Glucose-6-Phosphatase Inhibitor: An Approach to Develop a Pre-Clinical Glycogen Storage Disease Type I Modelpp. s372–s381